Compare GIII & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIII | NVAX |
|---|---|---|
| Founded | 1956 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2006 | 1996 |
| Metric | GIII | NVAX |
|---|---|---|
| Price | $36.36 | $7.44 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 9 |
| Target Price | ★ $29.00 | $11.33 |
| AVG Volume (30 Days) | 402.1K | ★ 3.1M |
| Earning Date | 06-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.29% | N/A |
| EPS Growth | N/A | ★ 309.76 |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $2,957,012,000.00 | $1,123,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $24.27 | ★ N/A |
| Revenue Growth | N/A | ★ 64.69 |
| 52 Week Low | $23.95 | $6.20 |
| 52 Week High | $37.00 | $11.85 |
| Indicator | GIII | NVAX |
|---|---|---|
| Relative Strength Index (RSI) | 58.71 | 33.78 |
| Support Level | $34.07 | $6.28 |
| Resistance Level | $36.43 | $10.10 |
| Average True Range (ATR) | 0.91 | 0.30 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 62.27 | 22.59 |
G-III Apparel Group Ltd is an apparel manufacturing company. The company makes a wide range of apparel, footwear, and accessories that sells under its own brands, licensed brands, and private-label brands. It has a substantial portfolio for licensed and proprietary brands, anchored by brands: DKNY, Donna Karan, Karl Lagerfeld, Karl Lagerfeld Paris, Vilebrequin, and others. The reportable segments of the company are Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, and sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenue from Wholesale operations.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.